Glycaemic control and cardiovascular risk factor management in patients with diabetes with and without coronary artery disease: insights from the diabetes mellitus status in Canada survey

European Heart Journal. Quality of Care & Clinical Outcomes
Jasmine GrenierAndrew T Yan

Abstract

Current diabetes guidelines recommend an individualized approach to glycaemic control. There are limited data on the contemporary and comprehensive management of patients with diabetes in relation to coronary artery disease (CAD). The Diabetes Mellitus Status in Canada (DM-SCAN) survey included 5123 patients with type 2 diabetes seen in primary care in November 2012. Primary care physicians (PCPs) collected clinical data and specified the A1C target for each patient on standardized forms. We compared management strategies and achievement of treatment targets in patients with and without CAD. Among the 4994 patients with data on CAD history, 22.5% had CAD. Primary care physicians were more likely to select a higher A1C target for patients with CAD (≤7.5 or ≤8.0%) versus without (≤7.0%). There was no difference in median A1C or in the proportion of patients with A1C ≤7.0% between the two groups. Compared with the group without known CAD, patients with CAD had a higher reported prevalence of hypoglycaemia in the preceding 6 months; more frequently received aspirin, statins, ACE inhibitors, or angiotensin receptor blockers, and were more likely to achieve blood pressure and low-density lipoprotein-cholesterol targets. Only 15.4 and...Continue Reading

References

Jan 10, 2001·Endocrinology and Metabolism Clinics of North America·J R White, R K Campbell
Aug 5, 2006·The American Journal of Medicine·Andrew T YanUNKNOWN Vascular Protection (VP) and Guidelines Oriented Approach to Lipid Lowering (GOALL) Registries Investigators
Feb 8, 2008·The New England Journal of Medicine·Peter GaedeOluf Pedersen
Jun 10, 2008·The New England Journal of Medicine·Anushka PatelFlorence Travert
Jun 10, 2008·The New England Journal of Medicine·UNKNOWN Action to Control Cardiovascular Risk in Diabetes Study GroupWilliam T Friedewald
Dec 19, 2008·The New England Journal of Medicine·William DuckworthUNKNOWN VADT Investigators
May 9, 2009·Clinical Journal of the American Society of Nephrology : CJASN·Maureen F MoenJeffrey C Fink
Mar 4, 2011·The New England Journal of Medicine·Sreenivasa Rao Kondapally SeshasaiUNKNOWN Emerging Risk Factors Collaboration
Apr 29, 2011·Diabetes Care·Anna Chudyk, Robert J Petrella
Oct 2, 2012·Diabetes, Obesity & Metabolism·L D Ferguson, N Sattar
Nov 8, 2012·Circulation. Cardiovascular Quality and Outcomes·M Odette GoreUNKNOWN National Registry of Myocardial Infarction Investigators
May 2, 2013·The Cochrane Database of Systematic Reviews·Bianca HemmingsenThomas Almdal
Aug 2, 2013·Diabetes Care·Edoardo MannucciPaolo Pozzilli
Aug 13, 2013·Journal of Diabetes Research·Xingguang ZhangXiaofeng Lv
Sep 18, 2013·The Canadian Journal of Cardiology·Esam A ElbarasiUNKNOWN Guidelines Oriented Approach in Lipid Lowering (GOALL) Registry and Vascular Protection (VP) Registry Investigators
Sep 28, 2013·Canadian Journal of Diabetes·Lawrence A LeiterAnatoly Langer
Dec 30, 2014·Diabetes Care
Jun 4, 2015·The New England Journal of Medicine·Rodney A HaywardUNKNOWN VADT Investigators
Dec 17, 2015·Circulation·Kim A ConnellySubodh Verma

❮ Previous
Next ❯

Citations

Aug 2, 2021·Journal of Diabetes and Its Complications·Samantha LoAndrew T Yan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Cardiovascular Risk Prediction

Cardiovascular risk prediction models based on classical risk factors identified in epidemiological studies are useful in primary prevention of cardiovascular disease in individuals. Here is the latest research.